Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?-Reference-Cited by-同舟云学术

Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?

Published:2024-07-02 Issue:1 Volume:332 Page:9
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Conte Caterina¹,Hall Kevin D.²,Klein Samuel³

Affiliation:

1. San Raffaele Roma Open University, Rome, Italy, and IRCCS MultiMedica, Milan, Italy

2. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland

3. Washington University School of Medicine in St Louis, St Louis, Missouri

Abstract

This Viewpoint explores the effects of weight loss achieved through GLP-1–based antiobesity medications on weight regain, fat-free mass, and skeletal muscle mass in people with obesity.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2819410/jama_conte_2024_vp_240047_1718902285.5685.pdf

Reference10 articles.

1. What is the pipeline for future medications for obesity?;Melson;Int J Obes (Lond),2024

2. Body fat and fat-free mass inter-relationships: Forbes’s theory revisited.;Hall;Br J Nutr,2007

3. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr.;Janssen;J Appl Physiol,2000

4. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity.;Magkos;Cell Metab,2016

5. Body composition changes following different types of bariatric surgery: interpreting discordant findings from different methodological approaches.;Sylivris;Obes Rev,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving equitable access to incretin-based therapies in cardiovascular care;American Heart Journal Plus: Cardiology Research and Practice;2024-10

2. Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy;American Journal of Roentgenology;2024-09-04

3. Muscle matters: the effects of medically induced weight loss on skeletal muscle;The Lancet Diabetes & Endocrinology;2024-09

4. “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services;Nutrition Bulletin;2024-08-13

5. Is It Time to Define Obesity by Body Composition and Not Solely Body Mass Index?;The Journal of Clinical Endocrinology & Metabolism;2024-07-12